Stock Events

Stock Events

MiNK Therapeutics (6Q40.F) Q2 2025 Earnings

15MayConfirmed

Q4 2024

Q1 2025

Q2 2025

-0.76

-0.66

-0.55

-0.44

Details

Expected EPS

-0.543028566

Actual EPS

-0.625506

Surprise EPS

-0.08

Surprise Percent

+15.19%

Description

MiNK Therapeutics (6Q40.F) has reported earnings of -0.625506 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.